Janus Global Life Sciences Fund (JAGLX)
Sector Experts Seeking Growth and Innovation in Health Care

SHARE CLASS

FUND FACTS (JAGLX)

Inception Date12/31/1998
NAV (As of 2/27/15 )$58.13
Total Net Assets (As of 1/31/15)$3.63B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.93%
NET 0.93%

Performance (As of 12/31/14)
1 Year34.83%
3 Year37.82%
5 Year24.85%
10 Year13.84%
Morningstar (As of 1/31/15)
CategoryHealth
Overall Rating™
(Based on risk-adjusted returns)

View All Ratings

119 Funds Rated
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Data as of 1/31/15. Index represents the MSCI World Health Care Index.

TOP HOLDINGS (% of Fund)

Biogen Idec, Inc. 2.98
Johnson & Johnson 2.93
Amgen, Inc. 2.55
Valeant Pharmaceuticals International, Inc. (U.S. Shares) 2.49
Pharmacyclics, Inc. 2.44
Celgene Corp. 2.31
Roche Holding AG 1.96
Endo International PLC 1.94
Boston Scientific Corp. 1.90
Aetna, Inc. 1.89
TOTAL23.39

CHARACTERISTICS

Number of Holdings
Equity Issues

98
Market Capitalization
Weighted Average
Median

$50.04B
$18.98B
Portfolio Turnover Ratio
(1-year trailing)

45.05%
Price/Earnings Ratio
(1-year forward)

21.46
Price/Book Ratio
(1-year forward)

9.57
Earnings Growth Rate
(1-year forward)

13.13%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Pharmacyclics, Inc.
Biogen Idec, Inc.
NPS Pharmaceuticals, Inc.
Valeant Pharmaceuticals International, Inc. (U.S. Shares)
Neurocrine Biosciences, Inc.
DETRACTORS
Tenet Healthcare Corp.
Johnson & Johnson
Amgen, Inc.
Swedish Orphan Biovitrum AB
AbbVie, Inc.

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 94.90 100.00
 
 
Financials 1.04 -
 
Consumer Staples 0.80 -
 
Cash & Equivalents 2.57 -
 
Restricted Cash 0.69 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 76.37 65.38
Non-U.S. Developed 19.54 34.62
Non-U.S. Emerging 0.83 -
Restricted Cash 0.69 -
Cash & Equivalents 2.57 -

REGIONS (%)

FUNDINDEX
North America 80.95 66.82
Europe 13.30 26.53
Africa/Mideast 1.66 1.14
Asia/Pacific Ex Japan 0.83 1.23
Cash & Equivalents 2.57 -
Restricted Cash 0.69 -

COUNTRIES (%)

FUNDINDEX
United States 76.37 65.38
Canada 4.57 1.44
Switzerland 4.56 10.29
United Kingdom 3.98 5.98
Israel 1.66 1.14
Germany 1.33 4.14
France 1.13 3.11
Denmark 1.10 2.35
Sweden 0.93 0.21
China 0.83 -
Netherlands 0.28 -
Cash & Equivalents 2.57 -
Restricted Cash 0.69 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 13.78 46.18
$50 Billion to $100 Billion 20.22 22.42
$10 Billion to $50 Billion 30.62 26.78
$5 Billion to $10 Billion 8.88 3.94
$1 Billion to $5 Billion 20.51 0.68
$500 Million to $1 Billion 4.04 -
$250 Million to $500 Million 0.58 -
N/A 1.37 -

TOP INDUSTRIES (%)

FUNDINDEX
Pharmaceuticals 36.46 56.65
Biotechnology 34.56 15.28
Health Care Equipment 7.05 10.81
Health Care Services 5.26 3.66
Health Care Facilities 3.46 0.97
Health Care Distributors 2.24 2.84
Managed Health Care 1.89 5.23
Life Sciences Tools & Services 1.82 2.91
Health Care Technology 1.51 0.57
Insurance Brokers 1.04 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.